AlternativeYentreve (SUI) / Cymbalta (depression)

Duloxetine

SNRI

Only licensed pharmacotherapy for stress urinary incontinence.

Oral

First-line for

  • Moderate–severe stress urinary incontinence (adjunct to pelvic floor training)
  • Depression / GAD / diabetic neuropathy

Mechanism

Serotonin + noradrenaline reuptake inhibition → central Onuf's nucleus stimulation → ↑ urethral sphincter tone.

"Duloxetine = Do pelvic floor first"

  • Physio + duloxetine >> either alone
  • Start low — nausea is the top drop-out reason
  • Suicidal ideation warning in <25s

Dosing

SUI start
20 mg BD × 2 weeks
SUI maintain
40 mg BD
Depression
60 mg OD; max 120 mg/day

Contraindications

  • AbsoluteConcurrent MAOI
  • AbsoluteSevere hepatic/renal impairment
  • AbsoluteUncontrolled narrow-angle glaucoma

Side effects

  • Nausea (50%)
  • Dry mouth, constipation
  • Insomnia, dizziness
  • Hepatotoxicity, hypertension
  • Discontinuation syndrome

Fetal & maternal notes

  • Limited data — avoid in pregnancy; if unavoidable, standard SSRI/SNRI cautions apply

Key interactions

  • MAOIs / tramadol / linezolid

    Avoid

    Serotonin syndrome

  • CYP1A2 inhibitors (ciprofloxacin, fluvoxamine)

    Caution

    ↑ duloxetine levels

Clinical pearls

  • 💡 Titrate slowly and take with food to survive the nausea window
  • 💡 Assess at 3 months — if no benefit, stop and refer for surgical options

Content last reviewed: REPLACE_ME (e.g. 2026-07)

Spotted something out of date? See our disclaimer or use Report an Error above.

For educational use only

Not medical advice. Verify dosing against the BNF and your local trust guidelines before prescribing.